Monomethyl fumarate Completed Phase 1 Trials for Relapsing Remitting Multiple Sclerosis (RRMS) Treatment

Indications	Status	Purpose	Phase
DBCOND0036413 (Relapsing Remitting Multiple Sclerosis (RRMS))	Completed	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT04570670	Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Subjects	Dimethyl fumarate (DB08908) Monomethyl fumarate (DB14219)
NCT05181215	Bioequivalence Study of Bafiertam 190 mg and Vumerity® 462 mg Delayed-Release Capsules in Fasting Healthy Subjects	Diroximel fumarate (DB14783) Monomethyl fumarate (DB14219)